Steinberg Global Asset Management lessened its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 40.6% during the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 19,412 shares of the company’s stock after selling 13,249 shares during the quarter. Steinberg Global Asset Management’s holdings in Henry Schein were worth $1,305,000 at the end of the most recent quarter.
Other institutional investors have also modified their holdings of the company. Headinvest LLC raised its stake in Henry Schein by 100.0% during the 4th quarter. Headinvest LLC now owns 13,160 shares of the company’s stock worth $1,033,000 after buying an additional 6,580 shares during the period. Royal London Asset Management Ltd. raised its stake in shares of Henry Schein by 81.5% in the 4th quarter. Royal London Asset Management Ltd. now owns 154,591 shares of the company’s stock valued at $12,046,000 after purchasing an additional 69,421 shares during the period. Man Group plc raised its stake in shares of Henry Schein by 6.0% in the 3rd quarter. Man Group plc now owns 167,444 shares of the company’s stock valued at $14,238,000 after purchasing an additional 9,542 shares during the period. JLB & Associates Inc. raised its stake in shares of Henry Schein by 2.7% in the 4th quarter. JLB & Associates Inc. now owns 57,301 shares of the company’s stock valued at $4,499,000 after purchasing an additional 1,483 shares during the period. Finally, Bessemer Group Inc. raised its stake in shares of Henry Schein by 1.8% in the 4th quarter. Bessemer Group Inc. now owns 23,991 shares of the company’s stock valued at $1,885,000 after purchasing an additional 420 shares during the period.
Several analysts have issued reports on the company. Zacks Investment Research downgraded Henry Schein from a “hold” rating to a “sell” rating in a research note on Wednesday, February 6th. BidaskClub raised Henry Schein from a “sell” rating to a “hold” rating in a research note on Thursday, February 7th. UBS Group assumed coverage on Henry Schein in a research note on Thursday, January 17th. They issued a “sell” rating and a $73.00 price target on the stock. Robert W. Baird downgraded Henry Schein from an “outperform” rating to a “neutral” rating and set a $76.60 price target on the stock. in a research note on Wednesday, January 2nd. Finally, ValuEngine raised Henry Schein from a “sell” rating to a “hold” rating in a research note on Monday, February 4th. Seven equities research analysts have rated the stock with a sell rating, six have issued a hold rating and six have given a buy rating to the stock. Henry Schein currently has a consensus rating of “Hold” and an average target price of $79.87.
Shares of NASDAQ HSIC opened at $61.89 on Tuesday. The stock has a market capitalization of $9.25 billion, a PE ratio of 14.99, a P/E/G ratio of 2.30 and a beta of 0.88. The company has a debt-to-equity ratio of 0.28, a current ratio of 1.30 and a quick ratio of 0.68. Henry Schein, Inc. has a fifty-two week low of $56.58 and a fifty-two week high of $91.35.
Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings data on Wednesday, February 20th. The company reported $1.12 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.11 by $0.01. The company had revenue of $3.38 billion during the quarter, compared to analysts’ expectations of $3.46 billion. Henry Schein had a return on equity of 19.86% and a net margin of 4.06%. Henry Schein’s revenue for the quarter was up 1.7% compared to the same quarter last year. During the same quarter last year, the company earned $0.97 EPS. As a group, sell-side analysts forecast that Henry Schein, Inc. will post 3.43 EPS for the current fiscal year.
In other news, Director Philip A. Laskawy sold 1,084 shares of the firm’s stock in a transaction dated Tuesday, March 12th. The stock was sold at an average price of $59.86, for a total value of $64,888.24. Following the completion of the transaction, the director now owns 32,899 shares in the company, valued at approximately $1,969,334.14. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 1.15% of the stock is owned by company insiders.
TRADEMARK VIOLATION WARNING: This report was originally published by Macon Daily and is the sole property of of Macon Daily. If you are reading this report on another domain, it was copied illegally and reposted in violation of international trademark & copyright laws. The correct version of this report can be read at https://macondaily.com/2019/04/16/henry-schein-inc-hsic-shares-sold-by-steinberg-global-asset-management.html.
Henry Schein Profile
Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Featured Story: Trading Strategy Methods and Types
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.